Lisa P. Rumin focuses her practice on antitrust, regulatory and litigation matters. She assists clients across a variety of industries and has represented numerous clients in the healthcare, pharmaceutical, and biotechnology industries. Lisa advises clients on mergers and acquisitions, including obtaining clearance from the Federal Trade Commission (FTC) and Department of Justice (DOJ), as well as counsels clients on issues regarding antitrust compliance, pricing, and distribution. She also counsels clients on cartel prosecutions and defenses, including government investigations and the initiation and defense of civil class action litigation. Lisa is experienced in areas of e-discovery, document review and production for investigations before the FTC, DOJ and state attorneys general office.

Mehr anzeigen

Ausgewählte Referenzmandate

  • Antitrust counsel to Mountain States Health Alliance in obtaining, over FTC staff opposition, approvals with antitrust immunity from Tennessee and Virginia for merger with Wellmont Health System
  • Represented several hospital systems in a Federal Trade Commission (FTC) and state attorney general merger investigations including in New York, Pennsylvania, and West Virginia

Mehr anzeigen


  • Washington, DC Super Lawyer, Antitrust 2020
  • Super Lawyers, Washington DC, Rising Star – Antitrust Litigation, 2018
  • Legal 500 US, 2021


  • American Bar Association, Antitrust Section
    • Exemptions and Immunities Committee, Young Lawyer Representative 2018-2019
    • Membership Advocate 2018-2019

Mehr anzeigen


Wake Forest University School of Law, JD, cum laude, Order of the Coif, 2013
Northwestern University, BA, 2010

District of Columbia

Courts / Agencies
US District Court for the District of Columbia
US District Court for the Eastern District of Michigan

Lisa P. Rumin

Einblicke & Events / Medien

Antitrust M&A Snapshot / August 5, 2021

Antitrust M&A Snapshot / May 3, 2021

Special Report / February 2021

Veröffentlichungen / October 2020